David M. Mott - Insider Trading & Ownership

Location
1119 St. Paul Street, Baltimore, MD
Summary
The estimated net worth of David M. Mott is at least $14.9M dollars as of June 24, 2025. David M. Mott is the Director of ARDELYX, INC. and owns shares of ARDELYX, INC. (ARDX) stock worth about $10.7M. David M. Mott is the Director of IMARA Inc. and owns shares of Enliven Therapeutics, Inc. (ELVN) stock worth about $3.47M. David M. Mott is the Director of NOVAVAX INC and owns shares of NOVAVAX INC (NVAX) stock worth about $704K. David M. Mott is the Director of Epizyme, Inc. and owns shares of Epizyme, Inc. stock worth about $23K.
Signature
/s/Mark J. Casey, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of David M. Mott

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ARDX ARDELYX, INC. Director $10.7M +$6.78M +171% Jun 18, 2025
ELVN, IMRA Enliven Therapeutics, Inc. Director $3.47M Jun 2, 2022
NVAX NOVAVAX INC Director $704K Jun 20, 2025
EPZM Epizyme, Inc. Director $23K Aug 12, 2022
ADAP Adaptimmune Therapeutics PLC Director Jul 1, 2024
MRSN Mersana Therapeutics, Inc. Director Jun 12, 2025

Insider Transactions Reported by David M. Mott:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.